5 year key figures

1) In 2019/20, excluding impacts from returns for credit related to the voluntary field corrective action in the Cochlear Implants segment of CHF 11.1 million.

2) In 2019/20, excluding one-time costs and returns for credit related to the voluntary field corrective action in the Cochlear Implants segment of CHF 21.8 million and restructuring costs in the Hearing Instruments segment of CHF 1.5 million (2018/19: CHF 8.8 million).

3) In 2019/20, excluding one-time costs and returns for credit related to the voluntary field corrective action in the Cochlear Implants segment of CHF 47.8 million and restructuring costs in the Hearing Instruments segment of CHF 18.6 million (2018/19: CHF 11.5 million). In 2017/18 (CHF 19.2 million) and 2016/17 (CHF 18.4 million) consisting of transaction cost and integration related restructuring costs in connection with the acquisition of AudioNova.

4) In 2019/20, reported income after taxes and reported basic earnings per share consider one-time positive transition impacts of the Swiss tax reform of CHF 64.1 million (2018/19: none) and negative impacts of the one-time costs and impacts from returns for credit related to the voluntary field corrective action in the Cochlear Implants segment of CHF 36.5 million and from restructuring costs in the Hearing Instruments segment (incl. tax impact) of CHF 13.7 million (2018/19: CHF 8.3 million), which have been excluded in adjusted income after taxes and adjusted basic earnings per share. In 2017/18 and 2016/17 adjusted for transaction cost and integration related restructuring costs in connection with the acquisition of AudioNova.

5) Stock dividend proposal to the Annual General Shareholders’ Meeting of June 11, 2020.

6) Cash and cash equivalents + other current financial assets (without loans) – current financial liabilities – current lease liabilities – non-current financial liabilities – non-current lease liabilities.

7) Receivables (incl. loans) + inventories – trade payables – current income tax liabilities – short-term contract liabilities – other short-term liabilities – short-term provisions.

8) Excluding goodwill and intangibles relating to acquisitions.

9) Equity – net cash/(debt).

10) Equity in % of total assets.

11) Cash flow from operating activities + cash flow from investing activities + payments for lease liabilities.

12) Free cash flow – cash consideration for acquisitions and from divestments, net of cash acquired/divested.

13) EBIT in % of capital employed (average). IFRS 16 opening adjustment on April 1, 2019 has been considered in average capital employed.